136
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Urine volatile organic compounds composition in mice bearing breast and melanoma tumors: effect of low-protein diet

, , , &
Pages 1-13 | Published online: 19 Jul 2018

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics. 2018. CA: Cancer J Clin. 2018;68:7–30.
  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: Cancer J Clin. 2015;65:87–108.
  • Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin. 2010;60:301–316.
  • Sever A, Abd Elkadir A, Matana Y, Gopas J, Zeiri Y. Biomarkers for detection and monitoring of B16 melanoma in mouse urine and feces. J Biomark. 2015;2015:841245.
  • Singletary SE. Rating the risk factors for breast cancer. Ann Surg. 2003;237:474–482.
  • McPherson K, Steel C, Dixon JM. ABC of breast diseases. Breast cancer—epidemiology, risk factors, and genetics. BMJ. 2000;321:624–628.
  • Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622–3634.
  • Chow WH, Gridley G, McLaughlin JK, et al. Protein intake and risk of renal cell cancer. J Natl Cancer Inst. 1994;86:1131–1139.
  • Levine ME, Suarez JA, Brandhorst S, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014;19(3):407–417.
  • Thorogood M, Mann J, Appleby P, McPherson K. Risk of death from cancer and ischaemic heart disease in meat and non-meat eaters. BMJ. 1994;308:1667–1670.
  • Chang-Claude J, Frentzel-Beyme R, Eilber U. Mortality patterns of German vegetarians after 11 years of follow-up. Epidemiology. 1992;3; 395–401.
  • Chang-Claude J, Frentzel-Beyme R. Dietary and lifestyle determinants of mortality among German vegetarians. Int J Epidemiol. 1993;22; 228–236.
  • Shirasu M, Touhara K. The scent of disease: volatile organic compounds of the human body related to disease and disorder. J Biochem. 2011;150:257–266.
  • Yoel U, Gopas J, Ozer J, Peleq R, Shvartzman P. Canine scent detection of volatile elements characteristic of malignant cells in cell culture. Isr Med Assoc J. 2015;17:567–570.
  • Williams H, Pembroke A. Sniffer dogs in the melanoma clinic? Lancet. 1989;333(8640):734.
  • Pickel D, Manucy GP, Walker DB, Hall SB, Walker JC. Evidence for canine olfactory detection of melanoma. Appl Animal Behav Sci. 2004;89(1):107–116.
  • D’Amico A, Bono R, Pennazza G, et al. Identification of melanoma with a gas sensor array. Skin Res Technol. 2008;14:226–236.
  • Abaffy T, Moller M, Riemer DD, Milikowski C, Defazio RA. A case report – volatile metabolomic signature of malignant melanoma using matching skin as a control. J Cancer Sci Ther. 2011;3:140–144.
  • Kwak J, Gallagher M, Ozdener MH, et al. Volatile biomarkers from human melanoma cells. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;931:90–96.
  • Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29(Suppl 1):S49–S52.
  • Mitra S, editor. Sample preparation techniques in analytical chemistry. Vol. 237. Hoboken, NJ: John Wiley & Sons; 2003.
  • Long GL, Winefordner JD. Limit of detection. A closer look at the IUPAC definition. Anal Chem.1983;55:712A–724A.
  • Shrivastava A, Gupta VB. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chronicles Young Sci 2011;2;21–25.
  • Stein SE. Chemical substructure identification by mass spectral library searching. J Am Soc Mass Spectrom. 1995;6:644–655.
  • Fontana L, Adelaiye RM, Rastelli AL, et al. Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer. Oncotarget. 2013;4:2451–2461.
  • Pettersson J, Karlsson PC, Goransson U, Rafter JJ, Bohlin L. The flavouring phytochemical 2-pentanone reduces prostaglandin production and COX-2 expression in colon cancer cells. Biol Pharm Bull. 2008;31:534–537.
  • Shabana MM, Fathy FI, Salama MM, Hashem MM. Cytotoxic and antioxidant activities of the volatile constituents of Brassica tournefortii gouan: growing in Egypt. Cancer Sci Res. 2013;1:1–4.
  • Martelli A, Canonero R, Cavanna M, Ceradelli M, Marinari UM. Cytotoxic and genotoxic effects of five n-alkanals in primary cultures of rat and human hepatocytes. Mutat Res. 1994;323:121–126.
  • Ray G, Batra S, Shukla NK, et al. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat. 2000;59:163–170.
  • Boyd NF, McGuire V The possible role of lipid peroxidation in breast cancer risk. Free Radic Biol Med. 1991;10:185–190.
  • Kovacs E, Stucki D, Weber W, Müller H. Impaired DNA-repair synthesis in lymphocytes of breast cancer patients. Eur J Cancer Clin Oncol. 1986;22:863–869.
  • Fuchs P, Loeseken C, Schubert JK, Miekisch W. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer. 2010;126:2663–2670.
  • Silva CL, Passos M, Câmara JS. Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers—a powerful strategy for breast cancer diagnosis. Talanta. 2012;89:360–368.
  • Natella F, Nardini M, Di Felice M, Scaccini C. Benzoic and cinnamic acid derivatives as antioxidants: structure-activity relation. J Agric Food Chem. 1999;47:1453–1459.
  • Tam JP, Wu CR, Liu W, Zhang JW. Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications. J Am Chem Soc. 1991;113:6657–6662.
  • Cavuoto P, Fenech MF. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat Rev. 2012;38:726–736.
  • Wang Z, Sun M, Wang C. Detection of melanoma cancer biomarker dimethyl disulfide using cavity ringdown spectroscopy at 266 nm. Appl Spectrosc. 2016;70:1080–1085.
  • Montesano R. Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis. J Supramol Struct Cell Biochem. 1981;17:259–273.
  • Napalkov NP, Pozharisski KM. Morphogenesis of experimental tumors of the esophagus. J Natl Cancer Inst. 1969;42.6;927–940.
  • Hanai Y, Shimono K, Oka H, Baba Y, Yamazaki K, Beauchamp GK. Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice. Cancer Cell Int. 2012;12:7.
  • Dutta D, Chong NS, Lim SH. ndogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications. J Breath Res. 2018;12:034002.
  • Heers H, Gut JM, Hegele A, et al. Non-invasive detection of bladder tumors through volatile organic compounds: a pilot study with an electronic nose. Anticancer Res. 2018;38(2):833–837.
  • Tong H, Wang Y, Li Y, et al. Volatile organic metabolites identify patients with gastric carcinoma, gastric ulcer, or gastritis and control patients. Cancer Cell Int. 2017;17:108.
  • Maddocks ODK, Athineos D, Cheung EC, et al. Modulating the therapeutic response of tumors to dietary serine and glycine starvation. Nature. 2017;544:372–376.